AU Patent

AU2002243508A1 — Alpha-aminoboronic acids prepared by novel synthetic methods

Assigned to Bristol Myers Squibb Co · Expires 2002-07-24 · 24y expired

What this patent protects

Patent listed against Merrem.

Drugs covered by this patent

Patent Metadata

Patent number
AU2002243508A1
Jurisdiction
AU
Classification
—
Expires
2002-07-24
Drug substance claim
No
Drug product claim
No
Assignee
Bristol Myers Squibb Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.